Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
Jiajia Chen(Peking University Shougang Hospital), Lanjuan Li(First People's Hospital of Yuhang District), Xiaowei Xu(Guangdong Academy of Medical Sciences), Xiahong Dai(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Charlie Xiang(Zhejiang Chinese Medical University), Lijun Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Lü Chen(Wuhan University), Liang Yu(Zhejiang University), Chenxia Hu(Huazhong University of Science and Technology), Xiaoqing Lu(Zhejiang University), Hainv Gao, Yixin Zhu(Zhejiang University), Lingling Tang(Guangdong University of Foreign Studies)
Cited by 252
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome
|The Lancet|2013|839
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655